Chemotherapy-free neoadjuvant pembrolizumab combined with trastuzumab and pertuzumab in HER2-enriched early breast cancer (WSG-KEYRICHED-1) a single-arm, phase 2 trial

Kuemmel, Sherko; Graeser, Monika; Schmid, Peter; Reinisch, Mattea; Feuerhake, Friedrich; Volk, Valery; Armeanu-Ebinger, Sorin; Schuetz, Leon; Kelemen, Olga; Schroeder, Christopher; Ossowski, Stephan; Jozwiak, Katarzyna; Kostara, Athina; Scheffen, Iris; Luedtke-Heckenkamp, Kerstin; Hilpert, Felix; Kentsch, Angela; Ziske, Carsten; Depenbusch, Reinhard; Braun, Michael; Blohmer, Jens Uwe; zu Eulenburg, Christine; Christgen, Matthias; Bartels, Stephan; Kreipe, Hans Heinrich; Wuerstlein, Rachel; Biehl, Claudia; Pelz, Enrico; Hartkopf, Andreas; Harbeck, Nadia; Gluz, Oleg

Chemotherapy-free neoadjuvant pembrolizumab combined with trastuzumab and pertuzumab in HER2-enriched early breast cancer (WSG-KEYRICHED-1) a single-arm, phase 2 trial

Autor(en):

Kuemmel, Sherko; Graeser, Monika; Schmid, Peter; Reinisch, Mattea; Feuerhake, Friedrich; Volk, Valery; Armeanu-Ebinger, Sorin; Schuetz, Leon; Kelemen, Olga; Schroeder, Christopher; Ossowski, Stephan; Jozwiak, Katarzyna; Kostara, Athina; Scheffen, Iris; Luedtke-Heckenkamp, Kerstin; Hilpert, Felix; Kentsch, Angela; Ziske, Carsten; Depenbusch, Reinhard; Braun, Michael; Blohmer, Jens Uwe; zu Eulenburg, Christine; Christgen, Matthias; Bartels, Stephan; Kreipe, Hans Heinrich; Wuerstlein, Rachel; Biehl, Claudia; Pelz, Enrico; Hartkopf, Andreas; Harbeck, Nadia; Gluz, Oleg

Tübinger Autor(en):